PT2632550T - Métodos e composições para tratar diarreia associada a vih - Google Patents

Métodos e composições para tratar diarreia associada a vih

Info

Publication number
PT2632550T
PT2632550T PT118372499T PT11837249T PT2632550T PT 2632550 T PT2632550 T PT 2632550T PT 118372499 T PT118372499 T PT 118372499T PT 11837249 T PT11837249 T PT 11837249T PT 2632550 T PT2632550 T PT 2632550T
Authority
PT
Portugal
Prior art keywords
compositions
methods
treating hiv
associated diarrhea
hiv associated
Prior art date
Application number
PT118372499T
Other languages
English (en)
Portuguese (pt)
Inventor
Forbes William
Bortey Enoch
King Steven
Chaturvedi Pravin
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2632550(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Publication of PT2632550T publication Critical patent/PT2632550T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PT118372499T 2010-10-31 2011-10-31 Métodos e composições para tratar diarreia associada a vih PT2632550T (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19

Publications (1)

Publication Number Publication Date
PT2632550T true PT2632550T (pt) 2017-08-02

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
PT118372499T PT2632550T (pt) 2010-10-31 2011-10-31 Métodos e composições para tratar diarreia associada a vih

Country Status (20)

Country Link
US (4) US8962680B2 (enExample)
EP (1) EP2632550B1 (enExample)
JP (2) JP6063385B2 (enExample)
CN (2) CN103370101A (enExample)
AU (1) AU2011320155B2 (enExample)
BR (1) BR112013010774A2 (enExample)
CA (1) CA2816416C (enExample)
DK (1) DK2632550T3 (enExample)
EC (1) ECSP13012650A (enExample)
ES (1) ES2635435T3 (enExample)
HK (1) HK1249036A1 (enExample)
HU (1) HUE035393T2 (enExample)
MX (1) MX348184B (enExample)
PE (1) PE20140036A1 (enExample)
PH (1) PH12013500857A1 (enExample)
PL (1) PL2632550T3 (enExample)
PT (1) PT2632550T (enExample)
RU (1) RU2597746C2 (enExample)
WO (1) WO2012058664A1 (enExample)
ZA (1) ZA201303136B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG161259A1 (en) 2006-05-01 2010-05-27 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
AU2007248183B2 (en) * 2006-05-01 2013-08-01 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
CA2816416C (en) 2010-10-31 2020-02-11 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
CA2893070A1 (en) * 2012-12-07 2014-06-12 Salix Pharmaceuticals, Ltd Methods and compositions for treating hiv-associated diarrhea
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
US11216742B2 (en) 2019-03-04 2022-01-04 Iocurrents, Inc. Data compression and communication using machine learning
JOP20220339A1 (ar) * 2020-06-19 2023-01-30 Napo Pharmaceuticals Inc طرق وتركيبات علاج الإسهال الناتج عن العلاج الكيميائي
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
JP4195728B2 (ja) 1996-10-16 2008-12-10 ナポ ファーマシューティカルズ,インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
WO2005074575A2 (en) * 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2007002173A1 (en) * 2005-06-22 2007-01-04 University Of Massachusetts Hiv-1 protease inhibitors, and methods of making and using them
JP2009524585A (ja) 2005-12-15 2009-07-02 バイエル・ヘルスケア・アクチェンゲゼルシャフト ウイルス感染を処置するためのジアリールウレア
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
AU2007248183B2 (en) 2006-05-01 2013-08-01 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
SG161259A1 (en) 2006-05-01 2010-05-27 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
EA023814B1 (ru) 2009-08-26 2016-07-29 Гленмарк Фармасьютикалс Лтд. Способ получения полимерных композиций на основе проантоцианидина для фармацевтических форм
US20120202876A1 (en) 2009-10-06 2012-08-09 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
CA2816416C (en) 2010-10-31 2020-02-11 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
RU2593014C2 (ru) 2011-01-27 2016-07-27 Гленмарк Фармасьютикалс Лимитед Способ производства проантоцианидиновой полимерной композиции
RU2014124981A (ru) 2011-12-22 2016-02-10 Гленмарк Фармасьютикалс Лимитед Неэнтеросолюбильная фармацевтическая композиция, содержащая крофелемер
CA2893070A1 (en) 2012-12-07 2014-06-12 Salix Pharmaceuticals, Ltd Methods and compositions for treating hiv-associated diarrhea

Also Published As

Publication number Publication date
EP2632550B1 (en) 2017-05-03
AU2011320155B2 (en) 2016-02-25
RU2597746C2 (ru) 2016-09-20
US8962680B2 (en) 2015-02-24
AU2011320155A1 (en) 2013-05-09
JP6310971B2 (ja) 2018-04-11
HUE035393T2 (en) 2018-05-02
MX348184B (es) 2017-06-02
US20150190367A1 (en) 2015-07-09
EP2632550A4 (en) 2014-04-23
DK2632550T3 (en) 2017-08-07
CA2816416A1 (en) 2012-05-03
WO2012058664A1 (en) 2012-05-03
ES2635435T3 (es) 2017-10-03
JP2013540826A (ja) 2013-11-07
PL2632550T3 (pl) 2017-10-31
RU2013123794A (ru) 2014-12-10
EP2632550A1 (en) 2013-09-04
MX2013004873A (es) 2013-08-21
US20140294903A1 (en) 2014-10-02
BR112013010774A2 (pt) 2017-03-21
US9585868B2 (en) 2017-03-07
CN103370101A (zh) 2013-10-23
ECSP13012650A (es) 2013-10-31
PH12013500857A1 (en) 2018-01-17
CN107595836A (zh) 2018-01-19
US20120107370A1 (en) 2012-05-03
CA2816416C (en) 2020-02-11
US20120184605A1 (en) 2012-07-19
PE20140036A1 (es) 2014-01-31
ZA201303136B (en) 2016-01-27
JP2017019806A (ja) 2017-01-26
JP6063385B2 (ja) 2017-01-18
HK1249036A1 (zh) 2018-10-26

Similar Documents

Publication Publication Date Title
PT2632550T (pt) Métodos e composições para tratar diarreia associada a vih
BR112012024303A2 (pt) composição modificada para impacto e artigo fabricado
BR112013019732A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
EP2758441A4 (en) MODIFIED POLYETHYLENE COMPOSITIONS
CO6990720A2 (es) Composiciones que comprenden galatos y galamidas
BR112013015452A2 (pt) composições e métodos para modular fxr
PT3278800T (pt) Composições e métodos para melhorar a função mitocondrial e tratar condições patológicas relacionadas com músculos
PL2976946T3 (pl) Kompozycje cyklodekstryny, wyroby i sposoby
CL2013000460A1 (es) Polipeptidos que enlazan miostatina, composiciones y metodos
CL2014003386A1 (es) Métodos y composiciones para producción de biometano
SG11201502989XA (en) Compositions and methods for treating proteinopathies
LT3702351T (lt) Kompozicijos, apimančios mek inhibitorių
BR112012031033A2 (pt) composição de si--g-poliolefina e processo para fazer uma composição de si-g-poliolefina
BRPI1013927A2 (pt) métodos e composições para o tratamento de lúpus
EP2755486A4 (en) DISINFECTING COMPOSITIONS AND USES THEREOF
IL232648A0 (en) Preparations and methods for treating glioma
EP2785176A4 (en) ANTIMICROBIAL COMPOSITIONS AND CORRESPONDING METHODS
EP2928560A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA
EP2879670A4 (en) ANTIBACTERIAL COMPOSITIONS AND METHOD
BR112014001249A2 (pt) composições de amaciante e desaglutinação
EP2668044A4 (en) COMPOSITIONS AND THEIR USE
PL2578083T3 (pl) Kompozycje oczyszczające i odkażające
EP2744775A4 (en) BAX AGONIST, COMPOSITIONS AND RELATED METHODS
ZA201307701B (en) Compositions and methods for treating multi-drug resistant malaria
BR112014010769A2 (pt) métodos e composições para neuroproteção